CAS: 850664-21-0; N-(3-((2-(4-Amino-1,2,5-Oxadiazol-3-yl)-1-Ethyl-1H-Imidazo[4,5-C]Pyridin-6-yl)Oxy)Phenyl)-4-(2-Morpholinoethoxy)Benzamide

该化合物是一个复杂的有机化合物,其特点是多功能结构,包括苯甲胺核心,一丁二二二恶英和各种替代成分,如氨基和氧化氮组.该化合物一般被归类为医药中间体或潜在药物候选体,原因是其不同功能组可能与生物目标发生相互作用.其分子结构表明,特别是在针对特定途径或疾病的治疗方法或疾病的研制过程中,有可能在医药化学中应用.氧化氮和氨基苯丙胺环的存在可能有助于其生物活动,可能提高它的功效和选择性.此外,氨基苯基会影响其溶性与药理学特性.随着许多复杂的有机化合物的处理,合成,稳定性和再活动环境而应关注其生物研究与再活动.

结构式图片

上下游产品

4-{6-[(3-aminophenyl)oxy]-1-ethyl-1H-imidazo[4,5-c]pyridin-2-yl}-furazan-3-amine 4-chloro-2-hydroxy-5-nitropyridine 2-chloro-N-ethyl-5-nitro-4-pyridinamine N-(3-{[5-amino-4-(ethylamino)-2-pyridinyl]oxy}phenyl)-4-methylbenzenesulfonamide

合成工艺路线路线简述

  • 84449-78-5 + 850663-66-0 = 850664-21-0
    反应条件:1.1 Reagents: Oxalyl Chloride Catalysts: Dimethylformamide Solvents: Dichloromethane; Rt -> Reflux1.2 Reagents: Pyridine Solvents: Dichloromethane; Rt -> 70 °C
    标题:Discovery Of Aminofurazan-Azabenzimidazoles As Inhibitors Of Rho-Kinase With High Kinase Selectivity And Antihypertensive Activity
    作者:Stavenger,Robert A.; Cui,Haifeng; Dowdell,Sarah E.; Franz,Robert G.; Gaitanopoulos,Dimitri E.; Et Al
    参考文献:Journal Of Medicinal Chemistry 日期:2007 卷标:50(1) 页码:2-5
📜4-羟基-3-硝基吡啶置于palladium On Activated Charcoal 吡啶,盐酸,叔丁基过氧化氢,硫酸,Potassium Tert-Butylate,氢气,羟胺,Potassium Carbonate,溶剂黄146,盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺,三乙胺,Sodium Nitrite,三氯氧磷体系中,用 四氢呋喃,1,4-二氧六环,甲醇,癸烷,二氯甲烷,氨,水,重水,N,N-二甲基甲酰胺,甲苯 作为反应溶剂,-35.0~110.0 °C,500.0 Kpa 条件下,反应 109.0H,反应生成 N-[3-[[2-(4-氨基呋咱-3-基)-1-乙基-1H-咪唑并[4,5-C]吡啶-6-基]氧]苯基]-4-[[2-(4-吗啉基)乙基]氧]苯甲酰胺
参考文献:Discovery Of Aminofurazan-Azabenzimidazoles As Inhibitors Of Rho-Kinase With High Kinase Selectivity And Antihypertensive Activity
标题:Discovery Of Aminofurazan-Azabenzimidazoles As Inhibitors Of Rho-Kinase With High Kinase Selectivity And Antihypertensive Activity
摘要:The Discovery,Proposed Binding Mode,And Optimization Of A Novel Class Of Rho-Kinase Inhibitors Are Presented. Appropriate Substitution On The 6-Position Of The Azabenzimidazole Core Provided Subnanomolar Enzyme Potency In Vitro While Dramatically Improving Selectivity Over A Panel Of Other Kinases. Pharmacokinetic Data Was Obtained For The Most Potent And Selective Examples And One (6N) Has Been Shown To Lower Blood Pressure In A Rat Model Of Hypertension.
DOI:10.1021/jm060873P

海关参考信息

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献


1: Wróbel A, Rechberger T. The Influence of Maxacalcitol, Vitamin D(3) Analog, on Detrusor Overactivity in Conscious Rats. Urology. 2016 Mar 23. pii: S0090-4295(16)00296-X. doi: 10.1016/j.urology.2016.03.008. [Epub ahead of print] doi: 10.1096/fj.13-237040. Epub 2013 Sep 27.

合成参考文献


参考文献:10.1124/mol.119.115964
摘要:Lee TD, Lee OW, Brimacombe KR, Chen L, Guha R, Lusvarghi S, Tebase BG, Klumpp-Thomas C, Robey RW, Ambudkar SV, Shen M, Gottesman MM, Hall MD. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. Molecular Pharmacology. 2019 Nov;96(5):629–40. doi: 10.1124/mol.119.115964.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知